Project

TRACER

Completed ยท 2008 until 2011

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2008
End Date
2011
Financing
Industry
Study Design
Multicenter, randomized, double-blind, placebo-controlled
Keywords
-
Brief description/objective

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with acute Coronary Syndrome :
Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)